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Objectives: To assess the effect of vitamin B-12 complex injection on the nephrotoxicity of gentamicin.  
Design: Experimental study using a pre-validated model.  
Subject: Adult Swiss albino rats weighing 140-214g, Generic gentamicin sulphate injection and Vitamin B-12complex 
injection containing 2500mcg Cyanocobalamin, 12mg Niacinamide, 0.7 mg Folic acid  and 150 mg Ascorbic acid in  
twin ampoules to be combined fresh before administration.  
Setting: A pharmacological research laboratory in a tertiary institute 
Results: In Swiss albino rats, both 0.5mls/kg/day and 1mls/kg/day of B-12 complex injection for 5 days significantly 
and dose dependently exacerbated the increase in serum urea and creatinine caused by 80mg/k/day of gentamicin 
while both doses of B-12 complex injection given for 10 days significantly and dose dependently ameliorated the 
increase in serum urea and creatinine caused by 80mg/k/day of gentamicin (reversal of effect).  
Conclusion: 0.5mls/kg/day of B-12 complex injection for 5 days exacerbated gentamicin nephrotoxicity while the 
same dose for longer duration or 1ml/kg/day of B-12 complex ameliorated the toxicity. The exacerbation is probably 
due to the ascorbic acid component while the reversal is probably due to the other components acting directly or 
through a time dependent pharmacological advantage.  
 




 The introduction of the aminoglycoside 
antibiotics to clinical medicine in 1944 (Gilbert, 1991) 
heralded an era of triumph over gram negative 
pathogens and, previously disastrous, sepsis. 
Nephrotoxicity and ototoxicity are continuing concerns 
with the use of this class of drug. Nephrotoxicity occurs 
in 10-20% of patients despite various preventive efforts 
including the use of longer interval dosing regimens and 
strict monitoring of drug levels (Gilbert, 1991). An 
antidote to aminoglycoside nephrotoxicity would be a 
welcome addition to these efforts. Gentamicin is 
amongst the most commonly prescribed aminoglycoside 
sand the one with extensive research aimed at 
illuminating its pathway to toxicity (Rybak and 
Ramkumar, 2007). Results of these studies suggest a 
redundant pathway to nephrotoxicity (Martinez-Salgado, 
et al., 2007) and this may be part of the explanation for 
the clinical failures of single antidotes. Furthermore, 
suggested antidotes like herbal extracts and calcium 
modulators are difficult to introduce for the sole purpose 
of prevention of nephrotoxicity. Safer antidotes with wide 
treatment experience may be easier to introduce into 
practice. Vitamin B-12 complex is a combination 
preparation of vitamin B frequently used in the geriatric 
patients, who are also at increased risk of adverse drug 
effects. It is formulated as twin ampoules to be 
combined fresh before administration. One ampoule 





12mg of B3 (Niacinamide) and 0.7 mg of Folic acid in 
1mls while the twin ampoule contains 150 mg of 
Ascorbic acid (Vitamin C) in 1.5mls. When combined for 
administration, the solution is 2.5mls. This combination 
may interact with the renal effect of gentamicin and is 
probably nephroprotective because it contains anti-
oxidants (Khadkhodaee, et al., 2007). This study was 




 Adult, female, Swiss albino rats weighing140 to 
214g were obtained from the breeding unit of the 
Veterinary research institute, Vom, Nigeria and 
randomized into 4 groups of 4 rats each. The rats were 
housed in separate cages per group at a room 
temperature of 23 ± 3°C and relative humidity of 53-
60%, 12 hours light and 12 hours darkness cycles, fed 
ad-libitum on water and standard chow, and 
acclimatized for 14 days before experimentation. The 
groups were allocated to receive the following: Group 1: 
Gentamicin only at 80mg/kg/day intramuscularly (i.m.) 
for 10days; Group 2: Gentamicin 80mg/kg/day i.m. plus 
0.5mls of B-12 complex /kg /day for 10 days; Group 3: 
Gentamicin 80 mg /kg/day i.m.  plus 1mls of B-12 
complex /kg /day for 10 days and Group 4: Sham 
injection daily for 10 days. B-12 complex (ELDERVIT-
12, Elder Pharmaceutical Ltd, Mumbai, India (National 
agency for food and drug administration and control 
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     Day 0      Day 5      Day 10 
combinations as previously described and Gentamicin 
sulphate injection (Gentalek 
R
 , Lek Pharmaceutical and 
Chemical company, Veroskova, Slovenia. NAFDAC 04-
0220) purchased from a registered pharmaceutical 
company were used (stock solution) for the study. The 
dose of gentamicin used has been consistently 
demonstrated to induce nephrotoxicity in adult rats 
(Soliman, et al., 2007) while the dose of B-complex used 
was the pharmacological equivalent (in rats) of the usual 
clinical dose in man (Ghosh, 1984). Animals were 
weighed every alternate day and the last known weight 
was used for dose calculations.  Blood samples were 
collected by tail bleeding at day zero (day 1 being the 
day treatment was started) and the other blood samples 
were collected by cardiac puncture 24 hours after the 
last injection. Each sample was collected into a sterile 
sample bottle without anticoagulant and the serum was 
obtained for analysis. Serum Creatine and Serum Urea 
were the parameters of interest and were quantified 
using reagent kits from Bio-Analytics Company (Palm 
City, U.S.A.). Data was analyzed using Microsoft excel 
add-on, Analyze-it, and SATS softwares.  Student’s t-
test was used for within group comparison and 1-way 
ANOVA with Bonferroni error correction was used for 




 There was no significant difference (P>0.05) in 
the body weight of the animals throughout the duration 
of the study. There was no significant difference 
(P>0.05) in the serum creatine and serum urea between 
the groups at beginning of the study (day 0). In group 2, 
both the Serum creatine (Fig.1) and Urea (Fig. 2) 
significantly (P<0.05) and progressively increased 
throughout the duration of the study. In group 3, the 
serum creatine and urea were significantly (P<0.05) 
higher than both groups 1 and 2 by day 5.  By day 10, 
these values remained higher than group 1 but were 
significantly (p<0.05) lower than group 2. In the group 4, 
the serum creatine and urea followed these same 
patterns by days 5 and 10 but were significantly 
(P<0.05) lower than groups 2 and 3 (Table 1).    
 
Table 1: Weight, Serum Urea and Serum Creatine values in Swiss Albino rats 
Parameter            Weight(g)  Serum Creatine 
(mg/dl) 
   Serum Urea 
    (mmol/l) 
Group Day0 Day5 Day10 Day0 Day5 Day10 Day0 Day5 Day10 
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 Our results showed that 80mg /kg/day of 
gentamicin injection significantly and progressively 
increased serum creatinine and urea in Swiss albino rats 
throughout the 10 days of dosing and thus further 
validate this protocol as a reliable model of gentamicin 
nephrotoxicity. B-12 complex dose dependently 
worsened gentamicin toxicity in the first 5 days of dosing 
but dose-dependently ameliorated gentamicin induced 
nephrotoxicity in the last 5 days of dosing. This reversal 
of effect was unpredicted but may be explained by 
various components of the B-12 complex injection 
having opposite effects with enhancement of 
nephrotoxicity being favored on acute dosing and 
amelioration being favored on longer term dosing.   Our 
data can only be extrapolated to the B-12 complex as a 
unit but it may be important to recall that of the 5 
components of B-12 complex injection, only ascorbic 
acid has been reported to be nephrotoxic in rats at 1g/kg 
(Abraham, 2005) though this dose is much higher than 
the 30mg/kg/day and 60mg/kg /day of ascorbic acid in 
the B-12 complex used in this experiment.  It is possible 
that the nephrotoxicity of ascorbic acid operates through 
a mechanism that synergizes with that of gentamicin. It 
may be important to conduct further studies to evaluate 
this hypothesis. Though a number of studies have found 
dose-dependent nephrotoxicity with many drugs 
(Greggi-Atunes, et al., 2000, Martinez-Salgado, et al., 
2007,) at least one study has reported a reversal of 
effect similar to ours (Appenroth, et al., 1994). Our 
findings could be of immense clinical importance if 
confirmed by further studies because it would caution 
against co-administration of gentamicin and B-12 
complex parenterally and suggest that careful evaluation 
of patients on concurrent treatment with both drugs may 
be crucial, especially at the initial phase of treatment.  
The amelioration of gentamicin induced nephrotoxicity in 
the last 5 days of dosing is reassuring because it occurs 
in the period that significant gentamicin accumulation 
and higher incidence of nephrotoxicity is known to occur 




 Vitamin B-12 complex injection has an 
ambiguous effect on the nephrotoxicity of gentamicin 
which depends on the dose and duration of treatment. It 
may potentate gentamicin induced nephrotoxicity on 
short term use and may ameliorate it on longer term 
administration.  These findings are preliminary but 
clinically important. Further studies are necessary to 
confirm the findings and to elucidate any 
histopathological changes that may be associated with 
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LEGENDS TO FIGURES 
Figure 1:  Effect of Vitamin B-12 injection on the serum 
 creatine of Swiss Albino rats 
G1: Control 
G2:   Inj. Gentamicin 80mg i.m daily for 10 days 
G3: Inj. Gentamicin 80mg  i.m daily for 10 days plus inj. 
B-12 , 0.5mls daily for 10 days. 
G4: Inj. Gentamicin 80mg i.m daily for 10days plus inj. 
B-12, 1mls daily for 10days. 
B-12:  B-12 complex containing 1000mcg of Vitamin B-
12 (Cyanocobalamin), 4.8mg of B3 (Niacinamide) and 
0.28 mg  of Folic acid and 60 mg of Ascorbic acid 
(Vitamin C) in 1mls 
 
Figure 2: Effect of Vitamin B-12 injection on the serum 
 urea of Swiss Albino rats 
G1: Control 
G2:   Inj. Gentamicin 80mg i.m daily for 10 days 
G3: Inj. Gentamicin 80mg  i.m daily for 10 days plus inj. 
B-12, 0.5mls daily for 10 days. 
G4: Inj. Gentamicin 80mg i.m daily for 10days plus inj. 
B-12, 1mls daily for 10days. 
B-12:  B-12 complex containing 1000mcg of Vitamin B-
 12 (Cyanocobalamin), 4.8mg of B3 
 (Niacinamide) and 0.28 mg of Folic acid and 60 
 mg of Ascorbic acid (Vitamin C) in 1mls 
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